BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9504640)

  • 1. Two cases of inv(8)(p11q13) in AML with erythrophagocytosis: a new cytogenetic variant.
    Coulthard S; Chase A; Orchard K; Watmore A; Vora A; Goldman JM; Swirsky DM
    Br J Haematol; 1998 Mar; 100(3):561-3. PubMed ID: 9504640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute myeloid leukemia with inv(8)(p11q13).
    Panagopoulos I; Teixeira MR; Micci F; Hammerstrøm J; Isaksson M; Johansson B; Mitelman F; Heim S
    Leuk Lymphoma; 2000 Nov; 39(5-6):651-6. PubMed ID: 11342350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities of chromosome band 8p11 in leukemia: two clinical syndromes can be distinguished on the basis of MOZ involvement.
    Aguiar RC; Chase A; Coulthard S; Macdonald DH; Carapeti M; Reiter A; Sohal J; Lennard A; Goldman JM; Cross NC
    Blood; 1997 Oct; 90(8):3130-5. PubMed ID: 9376594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic and molecular remission in a case of acute myeloid leukaemia(AML) with inversion of chromosome 16 (Inv(16)) and Philadelphia chromosome (Ph).
    Preudhomme C; Lai JL; Plantier I; Demory JL; Zandecki M; Fenaux P
    Br J Haematol; 1992 Nov; 82(3):623-6. PubMed ID: 1486046
    [No Abstract]   [Full Text] [Related]  

  • 5. Type I MOZ/CBP (MYST3/CREBBP) is the most common chimeric transcript in acute myeloid leukemia with t(8;16)(p11;p13) translocation.
    Rozman M; Camós M; Colomer D; Villamor N; Esteve J; Costa D; Carrió A; Aymerich M; Aguilar JL; Domingo A; Solé F; Gomis F; Florensa L; Montserrat E; Campo E
    Genes Chromosomes Cancer; 2004 Jun; 40(2):140-5. PubMed ID: 15101047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consistent fusion of MOZ and TIF2 in AML with inv(8)(p11q13).
    Carapeti M; Aguiar RC; Watmore AE; Goldman JM; Cross NC
    Cancer Genet Cytogenet; 1999 Aug; 113(1):70-2. PubMed ID: 10459350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphologic characterization of acute myeloid leukemia with cytogenetic or molecular evidence of t(8;21), t(15;17), inv(16) and 11q23 abnormalities.
    Rozman M; Navarro JT; Domingo A; Ayats R; Vallespí T; Gallart M; Florensa L;
    Haematologica; 2002 Aug; 87(8):886-7. PubMed ID: 12161368
    [No Abstract]   [Full Text] [Related]  

  • 8. Inversion of chromosome 16 and uncommon rearrangements of the CBFB and MYH11 genes in therapy-related acute myeloid leukemia: rare events related to DNA-topoisomerase II inhibitors?
    Dissing M; Le Beau MM; Pedersen-Bjergaard J
    J Clin Oncol; 1998 May; 16(5):1890-6. PubMed ID: 9586906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic characterization of MOZ/CBP and CBP/MOZ chimeras in acute myeloid leukemia suggests the involvement of a damage-repair mechanism in the origin of the t(8;16)(p11;p13).
    Panagopoulos I; Isaksson M; Lindvall C; Hagemeijer A; Mitelman F; Johansson B
    Genes Chromosomes Cancer; 2003 Jan; 36(1):90-8. PubMed ID: 12461753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute myeloid leukemia with translocation (8;21) or inversion (16) in elderly patients treated with conventional chemotherapy: a collaborative study of the French CBF-AML intergroup.
    Prébet T; Boissel N; Reutenauer S; Thomas X; Delaunay J; Cahn JY; Pigneux A; Quesnel B; Witz F; Thépot S; Ugo V; Terre C; Recher C; Tavernier E; Hunault M; Esterni B; Castaigne S; Guilhot F; Dombret H; Vey N; ; ;
    J Clin Oncol; 2009 Oct; 27(28):4747-53. PubMed ID: 19720919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of therapy-related acute myeloid leukemia associated with inv(16), with subsequent development of t(9;22).
    Kim M; Lim J; Kim Y; Han K; Kang CS; Kim HJ; Min WS
    Leukemia; 2006 Apr; 20(4):746-8. PubMed ID: 16437154
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)].
    Perea G; Lasa A; Aventín A; Domingo A; Villamor N; Queipo de Llano MP; Llorente A; Juncà J; Palacios C; Fernández C; Gallart M; Font L; Tormo M; Florensa L; Bargay J; Martí JM; Vivancos P; Torres P; Berlanga JJ; Badell I; Brunet S; Sierra J; Nomdedéu JF;
    Leukemia; 2006 Jan; 20(1):87-94. PubMed ID: 16281071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature.
    Quesnel B; Kantarjian H; Bjergaard JP; Brault P; Estey E; Lai JL; Tilly H; Stoppa AM; Archimbaud E; Harousseau JL
    J Clin Oncol; 1993 Dec; 11(12):2370-9. PubMed ID: 8246025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic and clinical correlates in AML patients with abnormalities of chromosome 16.
    Marlton P; Keating M; Kantarjian H; Pierce S; O'Brien S; Freireich EJ; Estey E
    Leukemia; 1995 Jun; 9(6):965-71. PubMed ID: 7596186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis of minimally differentiated acute myeloid leukemia with chromosome 16 inversion.
    Sotomatsu M; Ogawa C; Shimoda M; Matsui A; Nakazawa S; Eguchi M; Morikawa A
    Leuk Lymphoma; 1997 Jan; 24(3-4):319-25. PubMed ID: 9156661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A further case of acute myeloid leukaemia with inv(8)(p11q13) and MOZ-TIF2 fusion.
    Billio A; Steer EJ; Pianezze G; Svaldi M; Casin M; Amato B; Coser P; Cross NC
    Haematologica; 2002 May; 87(5):ECR15. PubMed ID: 12010678
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytogenetically cryptic AML1-ETO and CBF beta-MYH11 gene rearrangements: incidence in 412 cases of acute myeloid leukaemia.
    Rowe D; Cotterill SJ; Ross FM; Bunyan DJ; Vickers SJ; Bryon J; McMullan DJ; Griffiths MJ; Reilly JT; Vandenberghe EA; Wilson G; Watmore AE; Bown NP
    Br J Haematol; 2000 Dec; 111(4):1051-6. PubMed ID: 11167739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A further case of acute myelomonocytic leukemia with inv(8) chromosomal rearrangement and MOZ-NCOA2 gene fusion.
    Murati A; Adélaïde J; Popovici C; Mozziconacci MJ; Arnoulet C; Lafage-Pochitaloff M; Sainty D; Birnbaum D; Chaffanet M
    Int J Mol Med; 2003 Oct; 12(4):423-8. PubMed ID: 12964013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study to determine whether trisomy 8, deleted 9q and trisomy 22 are markers of cryptic rearrangements of PML/RARalpha, AML1/ETO and CBFB/MYH11 respectively in acute myeloid leukaemia. MRC Adult Leukaemia Working Party. Medical Research Council.
    Langabeer SE; Grimwade D; Walker H; Rogers JR; Burnett AK; Goldstone AH; Linch DC
    Br J Haematol; 1998 May; 101(2):338-40. PubMed ID: 9609531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bulky lymphadenopathy in acute myeloid leukemia with inv (16) (p13q22): a case report].
    Zhou HF; Li JY; Qian SX; Qiu HR; Zhang SJ; Zhang JF; Wu YJ; Shen RL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Oct; 14(5):1033-7. PubMed ID: 17096914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.